Research Topic · Peer-Reviewed

Malignant Mixed Mullerian Tumor

Malignant mixed Mullerian tumor (MMMT), also known as carcinosarcoma, is a rare type of cancer that commonly arises in the female reproductive system. This aggressive cancer comes from the epithelial and mesenchymal cells of the uterus, ovaries or cervix, and can spread rapidly to other areas of the body such as the…

📚 0 peer-reviewed articles cited 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Malignant mixed Mullerian tumor (MMMT), also known as carcinosarcoma, is a rare type of cancer that commonly arises in the female reproductive system. This aggressive cancer comes from the epithelial and mesenchymal cells of the uterus, ovaries or cervix, and can spread rapidly to other areas of the body such as the lungs, liver and bones. Symptoms of MMMT can vary depending on the location of the cancer, however, most experience abdominal pain, abnormal vaginal bleeding, and an enlarged uterus. Since MMMT is a rare cancer, it can often be misdiagnosed which leads to a delay in treatment. There is no single known cause of MMMT, but there are several risk factors that can increase the likelihood of developing this type of cancer, such as advanced age, previous exposure to radiation therapy in the pelvic area, and a family history of certain cancers. In terms of treatment options, surgery is often the first step in removing the tumors from the reproductive system. Other treatments such as chemotherapy and radiation therapy may be used depending on the type and stage of cancer. At present, there are no specific methods to prevent the development of MMMT, but preventive measures such as regular screening and early detection may increase the chances of successful treatment. More research is needed to better understand the causes and treatment options for MMMT.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Hematology and Oncology Research yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.